Emily Holly
Women's Health · Starkville, MSNPI 1427693225
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 43 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $318 and has fallen 66.5% since, to $107 in 2025.
Across 43 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$165
- Daiichi Sankyo Inc.$132
- Exeltis, USA Inc.$99
- Mayne Pharma Commercial LLC$71
- Bayer$63
- Organon$63
- plus $161 from 6 others
What the payments were for
- Food & beverage$755100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 8 | $165 |
| Daiichi Sankyo Inc. | 7 | $132 |
| Exeltis, USA Inc. | 5 | $99 |
| Mayne Pharma Commercial LLC | 3 | $71 |
| Bayer | 4 | $63 |
| Organon | 7 | $63 |
| Hologic Sales And Service, LLC | 3 | $51 |
| Pfizer | 2 | $32 |
| Axonics, Inc. | 1 | $26 |
| Solventum Corporation | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Agile Therapeutics, Inc. | 1 | $12 |
How this compares
$755 in reported general payments places this provider in the 65th percentile of 66 women's health providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ValacyclovirValacyclovir Hcl | 20 | $995 |
| Estradiol | 28 | $653 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 19 | $504 |
| Metronidazole | 26 | $471 |
| Fluconazole | 32 | $104 |
| Medroxyprogesterone Acetate | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Other women's health in Starkville
- Casey HargettTupelo$7K
- Kathryn ElliottOxford$7K
- Jennifer FredricksonSouthaven$6K
- Wanda BrownOlive Branch$4K
- Deborah VerucchiSouthaven$3K
- Daphne HuttoPascagoula$3K
- Felecia BrownMeridian$3K
- Rachel FordJackson$3K
- Courtney MathisFlowood$2K
- Rebecca BatesFlowood$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.